Institut für Immunologie und Genetik
Industry / private company
Location:
Kaiserslautern,
Germany (DE)
Loss-of-function variants in the CAPN1 activator CD99L2 cause X-linked spastic ataxia (2026)
Menden B, Incebacak Eltemur RD, Demidov G, Sturm M, Park J, Huridou C, Fath F, et al.
Journal article
Therapeutic Drug Monitoring of Long-Acting Rilpivirine and Cabotegravir for Treatment of HIV-1 Infection - A Case Series of Five Patients With One Virologic Failure After Development of Two-Class Resistance (2024)
Gerstenberg J, Klinker H, Baier M, Von Braun A, Seybold U, Helbig C, Däumer M, et al.
Journal article